These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

846 related items for PubMed ID: 17070627

  • 1. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
    Jacques I, Verger JM, Laroucau K, Grayon M, Vizcaino N, Peix A, Cortade F, Carreras F, Guilloteau LA.
    Vaccine; 2007 Jan 15; 25(5):794-805. PubMed ID: 17070627
    [Abstract] [Full Text] [Related]

  • 2. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A, Jacques I, Grilló MJ, Marín CM, Grayon M, Blasco JM, Verger JM.
    Vaccine; 2004 Jul 29; 22(21-22):2827-35. PubMed ID: 15246618
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of bp26 and bp26/omp31 B. melitensis Rev.1 deletion mutants against Brucella ovis in rams.
    Grilló MJ, Marín CM, Barberán M, de Miguel MJ, Laroucau K, Jacques I, Blasco JM.
    Vaccine; 2009 Jan 07; 27(2):187-91. PubMed ID: 19007836
    [Abstract] [Full Text] [Related]

  • 4. Residual virulence and immunogenicity of CGV26 and CGV2631 B. melitensis Rev. 1 deletion mutant strains in sheep after subcutaneous or conjunctival vaccination.
    Guilloteau LA, Laroucau K, Olivier M, Grillo MJ, Marin CM, Verger JM, Blasco JM.
    Vaccine; 2006 Apr 24; 24(17):3461-8. PubMed ID: 16519974
    [Abstract] [Full Text] [Related]

  • 5. Use of recombinant BP26 protein in serological diagnosis of Brucella melitensis infection in sheep.
    Cloeckaert A, Baucheron S, Vizcaino N, Zygmunt MS.
    Clin Diagn Lab Immunol; 2001 Jul 24; 8(4):772-5. PubMed ID: 11427425
    [Abstract] [Full Text] [Related]

  • 6. Antibody response and antigen-specific gamma-interferon profiles of vaccinated and unvaccinated pregnant sheep experimentally infected with Brucella melitensis.
    Durán-Ferrer M, Léon L, Nielsen K, Caporale V, Mendoza J, Osuna A, Perales A, Smith P, De-Frutos C, Gómez-Martín B, Lucas A, Chico R, Delgado OD, Escabias JC, Arrogante L, Díaz-Parra R, Garrido F.
    Vet Microbiol; 2004 Jun 03; 100(3-4):219-31. PubMed ID: 15145500
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of humoral and cellular immune responses to BP26 and OMP31 epitopes in the attenuated Brucella melitensis vaccinated sheep.
    Wang W, Wu J, Qiao J, Weng Y, Zhang H, Liao Q, Qiu J, Chen C, Allain JP, Li C.
    Vaccine; 2014 Feb 07; 32(7):825-33. PubMed ID: 24370708
    [Abstract] [Full Text] [Related]

  • 8. Assessment of serological response of young and adult sheep to conjunctival vaccination with Rev-1 vaccine by fluorescence polarization assay (FPA) and other serological tests for B. melitensis.
    Stournara A, Minas A, Bourtzi-Chatzopoulou E, Stack J, Koptopoulos G, Petridou E, Sarris K.
    Vet Microbiol; 2007 Jan 17; 119(1):53-64. PubMed ID: 16973307
    [Abstract] [Full Text] [Related]

  • 9. Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams.
    Muñoz PM, Estevan M, Marín CM, Jesús De Miguel M, Jesús Grilló M, Barberán M, Irache JM, Blasco JM, Gamazo C.
    Vaccine; 2006 Mar 10; 24(11):1897-905. PubMed ID: 16337315
    [Abstract] [Full Text] [Related]

  • 10. Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against Brucella melitensis infection of sheep.
    Barrio MB, Grilló MJ, Muñoz PM, Jacques I, González D, de Miguel MJ, Marín CM, Barberán M, Letesson JJ, Gorvel JP, Moriyón I, Blasco JM, Zygmunt MS.
    Vaccine; 2009 Mar 10; 27(11):1741-9. PubMed ID: 19186196
    [Abstract] [Full Text] [Related]

  • 11. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
    Cassataro J, Pasquevich KA, Estein SM, Laplagne DA, Velikovsky CA, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH, Goldbaum FA.
    Vaccine; 2007 May 30; 25(22):4437-46. PubMed ID: 17442465
    [Abstract] [Full Text] [Related]

  • 12. Competitive enzyme-linked immunosorbent assay using monoclonal antibodies to the Brucella melitensis BP26 protein to evaluate antibody responses in infected and B. melitensis Rev.1 vaccinated sheep.
    Debbarh HS, Zygmunt MS, Dubray G, Cloeckaert A.
    Vet Microbiol; 1996 Dec 30; 53(3-4):325-37. PubMed ID: 9008343
    [Abstract] [Full Text] [Related]

  • 13. Serological and allergic reactions of ewes after simultaneous vaccinations with two living attenuated strains of Brucella and Salmonella.
    Pardon P, Sanchis R, Molenat G, Marly J, Renard D.
    Ann Rech Vet; 1990 Dec 30; 21(2):153-60. PubMed ID: 2360774
    [Abstract] [Full Text] [Related]

  • 14. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R, Contreras A, Sanakkayala N, Sriranganathan N, Boyle SM, Schurig GG.
    Vet Microbiol; 2004 Sep 08; 102(3-4):237-45. PubMed ID: 15327798
    [Abstract] [Full Text] [Related]

  • 15. Expression, purification, and improved antigenic specificity of a truncated recombinant bp26 protein of Brucella melitensis M5-90: a potential antigen for differential serodiagnosis of brucellosis in sheep and goats.
    Liu WX, Hu S, Qiao ZJ, Chen WY, Liu LT, Wang FK, Hua RH, Bu ZG, Li XR.
    Biotechnol Appl Biochem; 2011 Sep 08; 58(1):32-8. PubMed ID: 21446957
    [Abstract] [Full Text] [Related]

  • 16. Serological findings obtained in cattle herds immunised with the Brucella melitensis Rev.1 and the B. abortus B19 vaccine in Mongolia.
    Dénes B.
    Acta Vet Hung; 1997 Sep 08; 45(1):33-43. PubMed ID: 9270127
    [Abstract] [Full Text] [Related]

  • 17. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
    Winter AJ, Schurig GG, Boyle SM, Sriranganathan N, Bevins JS, Enright FM, Elzer PH, Kopec JD.
    Am J Vet Res; 1996 May 08; 57(5):677-83. PubMed ID: 8723881
    [Abstract] [Full Text] [Related]

  • 18. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
    Li ZQ, Shi JX, Fu WD, Zhang Y, Zhang J, Wang Z, Li TS, Chen CF, Guo F, Zhang H.
    Mol Immunol; 2015 Aug 08; 66(2):276-83. PubMed ID: 25899866
    [Abstract] [Full Text] [Related]

  • 19. Vaccine Candidate Brucella melitensis 16MΔvjbR Is Safe in a Pregnant Sheep Model and Confers Protection.
    Hensel ME, Garcia-Gonzalez DG, Chaki SP, Hartwig A, Gordy PW, Bowen R, Ficht TA, Arenas-Gamboa AM.
    mSphere; 2020 May 13; 5(3):. PubMed ID: 32404509
    [Abstract] [Full Text] [Related]

  • 20. Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization.
    Yang X, Walters N, Robison A, Trunkle T, Pascual DW.
    Vaccine; 2007 Mar 08; 25(12):2261-8. PubMed ID: 17239499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.